IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Proteostasis Therapeutics

Q1 2026 vs Q2 2026

Comparing institutional holders between quarters

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Broderick Brian C
UNCHANGED
Shares65,000 from 65,000
Change0 (0%)
Value$29.5K ($0)
Filed 2026-08-11
Status
Broderick Brian C
UNCHANGED65,00065,00000%$29.5K$29.5K$02026-08-11
Showing 1 of 1 institutions